As direct inhibition of the proteasome complex in solid tumors failed to provide significant clinical benefit [148], a deeper understanding of the role of E3 ubiquitin ligases in the regulation of p53 will provide valuable information for the development of effective anti-cancer drugs in a specific subset of solid tumors with WT-p53. The gene discussed is TP53; the disease is cancer.